Comment on "Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes".

Marasca, Claudio; Masarà, Anna; Annunziata, Maria Carmela; Fattore, Davide; Fabbrocini, Gabriella

Marasca, Claudio; Masarà, Anna; Annunziata, Maria Carmela; Fattore, Davide; Fabbrocini, Gabriella.

Afiliación

Marasca C; Department of Clinical Medicine and Surgery Section of Dermatology, University of Naples Federico II, Naples, Italy.
Masarà A; Department of Clinical Medicine and Surgery Section of Dermatology, University of Naples Federico II, Naples, Italy.
Annunziata MC; Department of Clinical Medicine and Surgery Section of Dermatology, University of Naples Federico II, Naples, Italy. Electronic address: marcia.annunziata@hotmail.it.
Fattore D; Department of Clinical Medicine and Surgery Section of Dermatology, University of Naples Federico II, Naples, Italy.
Fabbrocini G; Department of Clinical Medicine and Surgery Section of Dermatology, University of Naples Federico II, Naples, Italy.

J Am Acad Dermatol ; 88(5): e269, 2023 05.

Article en En | MEDLINE | ID: mdl-30872151

Asunto(s)

Clindamicina; Hidradenitis Supurativa; Humanos; Clindamicina/efectos adversos; Rifampin/uso terapéutico; Hidradenitis Supurativa/tratamiento farmacológico; Prevalencia; Antibacterianos/uso terapéutico

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Clindamicina / Hidradenitis Supurativa Tipo de estudio: Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Am Acad Dermatol Año: 2023 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google